skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sphingosine kinase inhibitor suppresses IL-18-induced interferon-gamma production through inhibition of p38 MAPK activation in human NK cells

Journal Article · · Biochemical and Biophysical Research Communications
; ; ;  [1];  [2];  [3];  [4];  [5]; ;  [6];  [1]
  1. Department of Life Science, Sookmyung Women's University, Hyochangwon-gil 52, Seoul 140-742 (Korea, Republic of)
  2. Faculty of Medicine, Imperial College London, London SW7 2AZ (United Kingdom)
  3. School of Life Science and Biotechnology, Korea University, Seoul (Korea, Republic of)
  4. Department of Dermatology, St. Mary's Hospital, College of Medicine, The Catholic University, Seoul (Korea, Republic of)
  5. Department of Animal Resource and Sciences, Dankook University, Cheonan (Korea, Republic of)
  6. Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea, Republic of)

Natural killer (NK) cells play an important role in the innate immune response. Interleukin-18 (IL-18) is a well-known interferon-gamma (IFN-{gamma} inducing factor, which stimulates immune response in NK and T cells. Sphingosine kinase (SPHK) catalyzes the formation of sphingosine 1-phosphate (S1P), which acts as a second messenger to function as an anti-apoptotic factor and proliferation stimulator of immune cells. In this study, to elucidate whether SPHK is involved in IL-18-induced IFN-{gamma} production, we measured IL-18-induced IFN-{gamma} production after pre-treatment with SPHK inhibitor (SKI) in NK-92MI cells. We found that IL-18-induced IFN-{gamma} expression was blocked by SKI pre-treatment in both mRNA and protein levels. In addition, the increased IFN-{gamma} production by stimulation with IL-18 is mediated through both SPHK and p38 MAPK. To determine the upstream signals of SKI and p38 MAPK in IL-18-induced IFN-{gamma} production, phosphorylation levels of p38 MAPK was measured after SKI pre-treatment. As a result, inhibition of SPHK by SKI blocked phosphorylation of p38 MAPK, showing that SPHK activation by IL-18 is an upstream signal of p38 MAPK activation. Inhibition of SPHK by SKI also inhibited IL-18-induced IFN-{gamma} production in human primary NK cells. In conclusion, SPHK activation is an essential factor for IL-18-induced IFN-{gamma} production via p38 MAPK.

OSTI ID:
21143852
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 374, Issue 1; Other Information: DOI: 10.1016/j.bbrc.2008.06.091; PII: S0006-291X(08)01270-9; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling
Journal Article · Sat Jun 10 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:21143852

Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation
Journal Article · Fri Aug 01 00:00:00 EDT 2014 · Experimental Cell Research · OSTI ID:21143852

Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation
Journal Article · Fri Jun 22 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:21143852